Vaxart, Inc. - VXRT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$837K
QoQ value delta ($000)
-$9.454M (-91.87%)
Implied price effect (QoQ)
-20.53%
Shares
Total shares
2,341,871
QoQ shares delta
-20,540,462 (-89.77%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VXRT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q2 2026 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
MARSHALL WACE, LLP 703 1,953,037 0.0%
XTX Topco Ltd 34 94,258 0.0%
HBK Sorce Advisory LLC 26 75,118 0.0%
Beacon Capital Management, LLC 22 60,314 0.0%
Custos Family Office, LLC 18 50,000 0.01%
LVM CAPITAL MANAGEMENT LTD/MI 9 25,000 0.0%
Heritage Wealth Advisors 8 21,984 0.0%
SIMPLEX TRADING, LLC 7 22,092 0.0%
OSAIC HOLDINGS, INC. 5 14,185 0.0%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 3 10,400 0.0%
Baader Bank Aktiengesellschaft 2 12,091 0.0%
UMB Bank, n.a. 0 100 0.0%
Rockefeller Capital Management L.P. 0 1,175 0.0%
Archer Investment Corp 0 15 0.0%
Concord Wealth Partners 0 75 0.0%
ORG Partners LLC 0 2,000 0.0%
Farther Finance Advisors, LLC 0 27 0.0%